Literature DB >> 6032510

Influence of isoleucine upon quinomycin biosynthesis by Streptomyces sp. 732.

T Yoshida, K Katagiri.   

Abstract

When dl-isoleucine was added to an ammonium nitrate-maltose medium during cultivation of Streptomyces sp. 732, quinomycin B formation was selectively enhanced (from 3 to 70% of the quinomycin mixture) and quinomycin C synthesis was inhibited completely. In addition, two new quinomycins, designated quinomycins D and E, were produced in the presence of isoleucine. These compounds were found to contain N-methylalloisoleucine. In experiments with isoleucine enantiomorphs, it was determined that the order of effectiveness for quinomycin B synthesis was dl-isoleucine > d-isoleucine > l-isoleucine. The extent to which quinomycin B synthesis is enhanced depends upon the concentration and the time of addition of isoleucine to the medium. The effect of dl-isoleucine was reduced to some extent by the addition of l-valine. It is conceivable that amino acids which are precursors of the N-methylamino acids in quinomycin can regulate quinomycin formation.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6032510      PMCID: PMC276604          DOI: 10.1128/jb.93.4.1327-1331.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

1.  Studies on quinoxaline antibiotics. II. Isolation and properties of quinomycins A, B and C.

Authors:  T YOSHIDA; K KATAGIRI; S YOKOZAWA
Journal:  J Antibiot (Tokyo)       Date:  1961-11       Impact factor: 2.649

2.  CONFIGURATION OF N,BETA-DIMETHYLLEUCINE, A CONSTITUENT AMINO ACID OF TRIOSTIN C.

Authors:  J I SHOJI; K TORI; H OTSUKA
Journal:  J Org Chem       Date:  1965-08       Impact factor: 4.354

3.  CONFIGURATION OF THE N-METHYLISOLEUCINE, A CONSTITUENT AMINO ACID OF TRIOSTIN B AND QUINOMYCIN B.

Authors:  H OTSUKA; J SHOKI
Journal:  J Antibiot (Tokyo)       Date:  1965-05       Impact factor: 2.649

4.  Biogenesis of the actinomycins.

Authors:  E KATZ
Journal:  Ann N Y Acad Sci       Date:  1960-10-05       Impact factor: 5.691

5.  CHANGES IN THE COMPOSITION OF AN ACTINOMYCIN COMPLEX DURING GROWTH OF A STREPTOMYCES CULTURE.

Authors:  W A Goss; E Katz; S A Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  1956-01       Impact factor: 11.205

6.  Isolation and structural study on minor components of quinoxaline antibiotics.

Authors:  H Otsuka; J I Shoji
Journal:  J Antibiot (Tokyo)       Date:  1966-05       Impact factor: 2.649

7.  Inhibition of formation of actiomycin by D-isoleucine.

Authors:  J KAWAMATA; M KIMURA; H FUJITA
Journal:  J Antibiot (Tokyo)       Date:  1960-05       Impact factor: 2.649

8.  Role of valine and isoleucine as regulators of actinomycin peptide formation by Streptomyces chrysomallus.

Authors:  E KATZ; C R WALDRON; M L MELONI
Journal:  J Bacteriol       Date:  1961-10       Impact factor: 3.490

  8 in total
  5 in total

1.  Branched-chain amino acid substitutions in the biosynthesis of the antibiotic actinomycin.

Authors:  T Yajim; K T Mason; E Kaltz
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  Effect of phosphate and amino acids on echinomycin biosynthesis by Streptomyces echinatus.

Authors:  J V Formica; M J Waring
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Preparation and DNA-binding properties of substituted triostin antibiotics.

Authors:  A Cornish; K R Fox; M J Waring
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

4.  Effect of branched-chain amino acids, valine, isoleucine and leucine on the biosythesis of bitespiramycin 4"-O-acylspiramycins.

Authors:  Zhen-Lin Li; Yong-Hong Wang; Ju Chu; Ying-Ping Zhuang; Si-Liang Zhang
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476

Review 5.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.